Kamal, N, Lindsay, MP, Cote, R, Fang, J, Kapral, MK, Hill, MD. Ten-year trends in stroke admissions and outcomes in Canada. Can J Neurol Sci. 2015;42:168-175.
Rothwell, PM, Coull, AJ, Giles, MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925-1933.
Kubo, M, Kiyohara, Y, Ninomiya, T, et al. Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology. 2006;66:1539-1544.
Jung, KH, Lee, SH, Kim, BJ, Y, et al. Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes. 2012;5:327-334.
Rothwell, PM, Warlow, CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64:817-820.
Hill, MD, Yiannakoulias, N, Jeerakathil, T, Tu, JV, Svenson, LW, Schopflocher, DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004;62:2015-2020.
Johnston, SC, Gress, DR, Browner, WS, Sidney, S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-2906.
Kleindorfer, D, Panagos, P, Pancioli, A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36:720-723.
Brown, RD Jr, Petty, GW, O’Fallon, WM, Wiebers, DO, Whisnant, JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke. 1998;29:2109-2113.
Lemesle, M, Milan, C, Faivre, J, Moreau, T, Giroud, M, Dumas, R. Incidence trends of ischemic stroke and transient ischemic attacks in a well-defined French population from 1985 through 1994. Stroke. 1999;30:371-377.
Buntinx, F, Devroey, D, Van Casteren, V. The incidence of stroke and transient ischaemic attacks is falling: a report from the Belgian sentinel stations. Br J Gen Pract. 2002;52:813-817.
Sundararajan, V, Thrift, AG, Phan, TG, Choi, PM, Clissold, B, Srikanth, VK. Trends over time in the risk of stroke after an incident transient ischemic attack. Stroke. 2014;45:3214-3218.
Lavallee, PC, Meseguer, E, Abboud, H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6:953-960.
Albers, GW, Caplan, LR, Easton, JD, et al. Transient ischemic attack—proposal for a new definition. N Engl J Med. 2002;347:1713-1716.
Sacco, RL, Kasner, SE, Broderick, JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064-2089.
Kokotailo, RA, Hill, MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005;36:1776-1781.
Deyo, RA, Cherkin, DC, Ciol, MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
Sacco, RL, Diener, HC, Yusuf, S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
Wang, Y, Wang, Y, Zhao, X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11-19.
Amarenco, P, Bogousslavsky, J, Callahan, A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
ADVANCE Collaborative Group, Patel, A, MacMahon, S, Chalmers, J, , et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.
Robitaille, C, Dai, S, Waters, C, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ. 2012;184:E49-56.
McAlister, FA, Wilkins, K, Joffres, M, Leenen, FH, Fodor, G, Gee, M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183:1007-1113.
Coutts, SB, Wein, TH, Lindsay, MP, Buck, B, Cote, R, Ellis, P, et al. Canadian Stroke Best Practice Recommendations: secondary prevention of stroke guidelines, update 2014. Int J Stroke. 2014 Dec 23.
Kernan, WN, Ovbiagele, B, Black, HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160-2236.
Patel, AD, Tan, MK, Angaran, P, et al. Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit). Am J Cardiol. 2015;115:641-666.
Hong, KS, Yegiaian, S, Lee, M, Lee, J, Saver, JL. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation. 2011;123:2111-2119.
Ovbiagele, B, Kidwell, CS, Saver, JL. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke. 2003;34:919-924.